You have 9 free searches left this month | for more free features.

daclizumab

Showing 1 - 25 of 45

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Aplastic Anemia, Pure Red Cell Aplasia, Diamond Blackfan Anemia Trial run by the NHLBI (Daclizumab)

Terminated
  • Aplastic Anemia
  • +2 more
  • Daclizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 15, 2021

Kidney Transplantation, Kidney Diseases, Kidney Failure Trial in London (Campath, Daclizumab)

Completed
  • Kidney Transplantation
  • +2 more
  • London, United Kingdom
    West London Renal and Transplant Centre, 4th Floor Ham House, Ha
Sep 1, 2021

DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly Trial in Durham (biological, other, procedure,

Completed
  • DiGeorge Anomaly
  • +4 more
  • Cultured Thymus Tissue for Implantation (CTTI)
  • +8 more
  • Durham, North Carolina
    Duke University Medical Center
Mar 23, 2022

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (biological, drug, procedure)

Completed
  • Leukemia
  • +3 more
  • daclizumab
  • +4 more
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 31, 2019

Relapsing-Remitting Multiple Sclerosis (RRMS) Trial in Worldwide (Daclizumab)

Terminated
  • Relapsing-Remitting Multiple Sclerosis (RRMS)
  • Daclizumab
  • Tampa, Florida
  • +10 more
Sep 25, 2019

Kidney Failure, Chronic Trial in Baltimore (Thymoglobulin, Daclizumab, Plasmapheresis)

Completed
  • Kidney Failure, Chronic
  • Baltimore, Maryland
    The Johns Hopkins University, School of Medicine
Dec 19, 2017

Transplant; Failure, Kidney Trial in Miami (Alemtuzumab, Daclizumab, Thymoglobulin)

Completed
  • Transplant; Failure, Kidney
  • Miami, Florida
    University of Miami Miller School of Medicine
Nov 5, 2017

Uveitis Trial run by the NEI (Daclizumab)

Completed
  • Uveitis
  • Daclizumab
  • Bethesda, Maryland
    National Eye Institute (NEI)
Jun 30, 2017

HIV Trial run by the NIAID (Daclizumab)

Completed
  • HIV Infections
  • Daclizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

Uveitis Trial run by the NEI (Daclizumab)

Completed
  • Uveitis
  • Daclizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

Non-infectious Intermediate and Posterior Uveitis Trial run by the NEI (Daclizumab)

Completed
  • Non-infectious Intermediate and Posterior Uveitis
  • Daclizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

Multiple Sclerosis, Relapsing-Remitting Trial run by the NINDS (Daclizumab)

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • Daclizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

Anterior Uveitis, Arthritis, Juvenile Idiopathic, Iritis Trial run by the NEI (Daclizumab)

Completed
  • Anterior Uveitis
  • +3 more
  • Daclizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 27, 2017

GVHD Trial in United States (Daclizumab, methylprednisolone, Placebo)

Completed
  • Graft Versus Host Disease
  • Daclizumab
  • +2 more
  • Boston, Massachusetts
  • +7 more
Jan 19, 2017

Heart Transplantation Trial in Spain (Daclizumab, Mycophenolate mofetil, Silrolimus)

Completed
  • Heart Transplantation
  • Daclizumab
  • +2 more
  • Barcelona, Spain
  • +13 more
Nov 1, 2016

Diabetes, Insulin-Dependent Trial in Worldwide (Islet Transplantation, Sirolimus, Tacrolimus)

Completed
  • Diabetes Mellitus, Insulin-Dependent
  • Islet Transplantation
  • +7 more
  • Miami, Florida
  • +8 more
Feb 6, 2017

Kidney Diseases, Kidney Transplantation, Kidney Transplant Trial in United States (Daclizumab, Mycophenolate mofetil (MMF),

Completed
  • Kidney Diseases
  • +4 more
  • Daclizumab
  • +6 more
  • Birmingham, Alabama
  • +11 more
Oct 19, 2016

Amount of Medications That May be Removed From Body During

Withdrawn
  • Kidney Transplantation
  • Plasmapheresis
  • New York, New York
  • +1 more
Oct 19, 2016

End-Stage Renal Disease Trial in Rockville (Daclizumab, Methylprednisolone/prednisone, Mycophenolate mofetil)

Completed
  • End-Stage Renal Disease
  • Daclizumab
  • +6 more
  • Rockville, Maryland
    Lauren Schenker
Oct 19, 2016

End Stage Renal Disease Trial in Charleston (Rabbit Antithymocyte globulin, Daclizumab)

Completed
  • End Stage Renal Disease
  • Rabbit Antithymocyte globulin
  • Daclizumab
  • Charleston, South Carolina
    Medical University of South Carolina
Mar 23, 2016

Kidney Transplantation Trial in United States (DT, Daclizumab, KLH)

Completed
  • Kidney Transplantation
  • DT
  • +2 more
  • Los Angeles, California
  • +4 more
Dec 9, 2015

Type 1 Diabetes Trial in Philadelphia (Allogeneic Pancreatic Islet Cells, Antithymocyte globulin, Daclizumab)

Terminated
  • Type 1 Diabetes Mellitus
  • Allogeneic Pancreatic Islet Cells
  • +4 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Feb 21, 2016

Cardiac Transplantation Trial in Houston (Daclizumab)

Terminated
  • Cardiac Transplantation
  • Daclizumab
  • Houston, Texas
    Baylor College of Medicine
Oct 14, 2015

Malignant Tumors of Brain Trial in Durham (biological, drug, other)

Completed
  • Malignant Neoplasms of Brain
  • PEP-3-KLH conjugate vaccine
  • +4 more
  • Durham, North Carolina
    Duke University Medical Center
Jan 20, 2016

Heart Transplantation Trial in Worldwide (Daclizumab, Methylprednisolone, Mycophenolate mofetil)

Completed
  • Heart Transplantation
  • Daclizumab
  • +4 more
  • Birmingham, Alabama
  • +29 more
May 4, 2016